Evidence map›Paper›PMID 39408847›Full record

ReviewInternational journal of molecular sciences2024

Therapeutic Potential of Momordicine I from

Pai-Feng Kao, Chun-Han Cheng, Tzu-Hurng Cheng, Ju-Chi Liu, Li-Chin Sung

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Observational
  4. Article
  5. Plants (Basel, Switzerland) · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pai-Feng KaoDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan.
Chun-Han ChengDepartment of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan.
Tzu-Hurng ChengDepartment of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung City 404333, Taiwan.
Ju-Chi LiuDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan.
Li-Chin SungDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan.ORCID 0000-0001-6292-7117

Funding

Ministry of Science and Technology, Taiwan MOST 108-2314-B038-115
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesMomordica charantiaAnimalsAnti-Inflammatory AgentsHumansPlant ExtractsSignal TransductionAnti-Inflammatory AgentsPlant Extractscardiovascular benefitsinflammationMomordica charantiamomordicine Ipharmacokinetics

Identifiers

PMID39408847
PMCPMC11477196

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.